Urate, Blood Pressure, and Cardiovascular DiseaseDipender Gill, Ioanna Tzoulaki, Verena Zuber et al.|Hypertension|2020Cited by 157
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke PreventionMaurizio Paciaroni, Simona Marcheselli, Giancarlo Agnelli et al.|Stroke|2019Cited by 95
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND StudyMaurizio Paciaroni, Lucia Pavolucci, Valeria Caso et al.|Stroke|2022Cited by 73
Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health NetworkTommaso Bucci, Gregory Y.H. Lip, Daniele Pastori et al.|Stroke|2024Cited by 41